Calcific Aortic Valve Stenosis and Atherosclerotic Calcification. 2020

Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
Division of Cardiovascular Surgery of Pronto Socorro Cardiológico de Pernambuco, PROCAPE, Av. Eng. Domingos Ferreira n°4172. Edf. Paquetá, apt° 405, Recife, Pernambuco, 51021-040, Brazil. michel_pompeu@yahoo.com.br.

This review summarizes the pathophysiology of calcific aortic valve stenosis (CAVS) and surveys relevant clinical data and basic research that explain how CAVS arises. Lipoprotein(a) [Lp(a)], lipoprotein-associated phospholipase A2 (Lp-PLA2), oxidized phospholipids (OxPL), autotaxin, and genetic driving forces such as mutations in LPA gene and NOTCH gene seem to play a major role in the development of CAVS. These factors might well become targets of medical therapy in the coming years. CVAS seems to be a multifactorial disease that has much in common with coronary artery disease, mainly regarding lipidic accumulation and calcium deposition. No clinical trials conducted to date have managed to answer the key question of whether Lp(a) lowering and anti-calcific therapies confer a benefit in terms of reducing incidence or progression of CAVS, although additional outcome trials are ongoing.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010727 Phosphoric Diester Hydrolases A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphodiesterase,Phosphodiesterases,Hydrolases, Phosphoric Diester
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001021 Aortic Valve The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. Aortic Valves,Valve, Aortic,Valves, Aortic
D001024 Aortic Valve Stenosis A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA. Aortic Stenosis,Aortic Valve Stenoses,Stenoses, Aortic,Stenoses, Aortic Valve,Stenosis, Aortic,Stenosis, Aortic Valve,Valve Stenoses, Aortic,Valve Stenosis, Aortic
D017270 Lipoprotein(a) A lipoprotein that resembles the LOW-DENSITY LIPOPROTEINS but with an extra protein moiety, APOPROTEIN (A) also known as APOLIPOPROTEIN (A), linked to APOLIPOPROTEIN B-100 on the LDL by one or two disulfide bonds. High plasma level of lipoprotein (a) is associated with increased risk of atherosclerotic cardiovascular disease. Lipoprotein (a),Lipoprotein (a-),Lipoprotein Lp(a),Lipoprotein a

Related Publications

Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
January 2015, Georgian medical news,
Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
October 2006, Acta cardiologica,
Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
October 2006, Herz,
Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
January 2007, The Journal of heart valve disease,
Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
December 2011, Arteriosclerosis, thrombosis, and vascular biology,
Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
January 2000, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi,
Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
March 1978, Ceskoslovenska patologie,
Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
May 1986, American heart journal,
Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
April 2001, Deutsche medizinische Wochenschrift (1946),
Michel Pompeu Barros de Oliveira Sá, and Luiz Rafael P Cavalcanti, and Álvaro M Perazzo, and Rafael A F Gomes, and Marie-Annick Clavel, and Philippe Pibarot, and Giuseppe Biondi-Zoccai, and Konstantin Zhigalov, and Alexander Weymann, and Arjang Ruhparwar, and Ricardo Carvalho Lima
January 2012, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese,
Copied contents to your clipboard!